Media Summary: Interview with CEO Christopher Moreau and host Cyndi Edwards regarding news about the next steps in CEO Chris Moreau discusses the recent Ifendprodil transaction with Seyltx and plans and milestones for Dr. Peter Todd and Dr. Erika Fullwood Augustine, Research Program Subcommittee members, discuss the key elements in writing ...

Algernon Neuroscience Reports Successful Second - Detailed Analysis & Overview

Interview with CEO Christopher Moreau and host Cyndi Edwards regarding news about the next steps in CEO Chris Moreau discusses the recent Ifendprodil transaction with Seyltx and plans and milestones for Dr. Peter Todd and Dr. Erika Fullwood Augustine, Research Program Subcommittee members, discuss the key elements in writing ... Paper link: Scientific discoveries often hinge on synthesizing decades of ... What choices can help us live long, productive lives? Will science someday identify ways to prevent aging altogether? Hear from ... Every brain contains a personal pharmacy located inside the blood-brain barrier that's open 24/7 and offers free delivery of its ...

00:00 Introduction 04:02 Dr. Adam Gazzaley(A new era of experiential medicine) 22:43 Dr. Paul Zak(The science of the ... Board Chair David W. Dodick, MD, FAAN hosted a special event to celebrate the 2023 class of our Next Generation Research ... This panel from the 2021 Longevity Innovations and Neurodegeneration Company Showcase (LINCS), co-hosted by NIA and the ... Gregory Samanez-Larkin - Decision Making in the Aging Brain Christopher Harvey, Harvard Medical School Harvey's cutting-edge work has redefined our understanding of how the brain gives ...

Photo Gallery

Algernon NeuroScience reports successful second cohort dosing in DMT clinical study
Algernon Pharmaceuticals plans Phase 2 stroke and TBI study after successful DMT single dose study
Algernon Pharmaceuticals subsidiary Algernon NeuroScience doses first patient in stroke study
Algernon Pharmaceuticals Forms Algernon NeuroScience Subsidiary to Advance DMT Stroke Program
Algernon Pharmaceuticals DMT Stroke Program Update and Recap with CEO Christopher Moreau
Algernon Pharmaceuticals Stroke/DMT Clinical Program
Algernon Pharmaceuticals  (AGN) CEO Chris Moreau Outlines DMT Stroke Research and Ifendprodil Plans
Algernon Pharmaceutical’s DMT Clinical Research Program for Stroke receives positive FDA feedback
What Makes a Successful Research Application? - American Academy of Neurology
Archive: The Neuroscience of Good Decision Making, Part 2 - 2014
Neuroccino 2nd December 2024 - LLMs surpase human experts in predicting neuroscience results
Approaching the Second Half of Life with Health and Vitality: Research on Longevity and Aging
Sponsored
Sponsored
View Detailed Profile
Algernon NeuroScience reports successful second cohort dosing in DMT clinical study

Algernon NeuroScience reports successful second cohort dosing in DMT clinical study

Algernon

Algernon Pharmaceuticals plans Phase 2 stroke and TBI study after successful DMT single dose study

Algernon Pharmaceuticals plans Phase 2 stroke and TBI study after successful DMT single dose study

Algernon

Sponsored
Algernon Pharmaceuticals subsidiary Algernon NeuroScience doses first patient in stroke study

Algernon Pharmaceuticals subsidiary Algernon NeuroScience doses first patient in stroke study

Algernon

Algernon Pharmaceuticals Forms Algernon NeuroScience Subsidiary to Advance DMT Stroke Program

Algernon Pharmaceuticals Forms Algernon NeuroScience Subsidiary to Advance DMT Stroke Program

Algernon

Algernon Pharmaceuticals DMT Stroke Program Update and Recap with CEO Christopher Moreau

Algernon Pharmaceuticals DMT Stroke Program Update and Recap with CEO Christopher Moreau

Interview with CEO Christopher Moreau and host Cyndi Edwards regarding news about the next steps in

Sponsored
Algernon Pharmaceuticals Stroke/DMT Clinical Program

Algernon Pharmaceuticals Stroke/DMT Clinical Program

Join Christopher J. Moreau, CEO of

Algernon Pharmaceuticals  (AGN) CEO Chris Moreau Outlines DMT Stroke Research and Ifendprodil Plans

Algernon Pharmaceuticals (AGN) CEO Chris Moreau Outlines DMT Stroke Research and Ifendprodil Plans

CEO Chris Moreau discusses the recent Ifendprodil transaction with Seyltx and plans and milestones for

Algernon Pharmaceutical’s DMT Clinical Research Program for Stroke receives positive FDA feedback

Algernon Pharmaceutical’s DMT Clinical Research Program for Stroke receives positive FDA feedback

Algernon

What Makes a Successful Research Application? - American Academy of Neurology

What Makes a Successful Research Application? - American Academy of Neurology

Dr. Peter Todd and Dr. Erika Fullwood Augustine, Research Program Subcommittee members, discuss the key elements in writing ...

Archive: The Neuroscience of Good Decision Making, Part 2 - 2014

Archive: The Neuroscience of Good Decision Making, Part 2 - 2014

The

Neuroccino 2nd December 2024 - LLMs surpase human experts in predicting neuroscience results

Neuroccino 2nd December 2024 - LLMs surpase human experts in predicting neuroscience results

Paper link: https://www.nature.com/articles/s41562-024-02046-9 Scientific discoveries often hinge on synthesizing decades of ...

Approaching the Second Half of Life with Health and Vitality: Research on Longevity and Aging

Approaching the Second Half of Life with Health and Vitality: Research on Longevity and Aging

What choices can help us live long, productive lives? Will science someday identify ways to prevent aging altogether? Hear from ...

The Power of a Smidgen: Applied BrainScience | Roger Anunsen | TEDxPortlandCommunityCollegeRockCreek

The Power of a Smidgen: Applied BrainScience | Roger Anunsen | TEDxPortlandCommunityCollegeRockCreek

Every brain contains a personal pharmacy located inside the blood-brain barrier that's open 24/7 and offers free delivery of its ...

Unlocking Success with Neuroscience│Adam Gazzaley, Paul Zak, and Dong-seon Chang

Unlocking Success with Neuroscience│Adam Gazzaley, Paul Zak, and Dong-seon Chang

00:00 Introduction 04:02 Dr. Adam Gazzaley(A new era of experiential medicine) 22:43 Dr. Paul Zak(The science of the ...

Next Generation Research Grant Recipients 2023

Next Generation Research Grant Recipients 2023

Board Chair David W. Dodick, MD, FAAN hosted a special event to celebrate the 2023 class of our Next Generation Research ...

Panel: Trending Areas in Aging and Neurodegeneration Science

Panel: Trending Areas in Aging and Neurodegeneration Science

This panel from the 2021 Longevity Innovations and Neurodegeneration Company Showcase (LINCS), co-hosted by NIA and the ...

Gregory Samanez-Larkin - Decision Making in the Aging Brain

Gregory Samanez-Larkin - Decision Making in the Aging Brain

Gregory Samanez-Larkin - Decision Making in the Aging Brain

2024 Troland Research Award

2024 Troland Research Award

Christopher Harvey, Harvard Medical School Harvey's cutting-edge work has redefined our understanding of how the brain gives ...

Algernon Pharma hits milestone in Phase 2b/3 human study of Ifenprodil enrolling 154th patient

Algernon Pharma hits milestone in Phase 2b/3 human study of Ifenprodil enrolling 154th patient

Algernon

The International Symposium on Clinical Neuroscience

The International Symposium on Clinical Neuroscience

ISCN is the premiere

Related Video Content

Flowers for Algernon - Wikipedia information

Flowers for Algernon is a short novelette [5] by American author Daniel Keyes, which he later expanded into a novel...

Flowers for Algernon by Daniel Keyes | Full Text information

Read about Flowers for Algernon by Daniel Keyes — analysis, themes, and discussion. A man's experimental journey from...

Algernon | Flowering Plant, Plant Genus, Plant Species | Britannica information

Algernon, fictional character, a witty man-about-town in Oscar Wilde ’s play The Importance Of Being Earnest (1895)....

Flowers for Algernon by Daniel Keyes | Goodreads information

Flowers for Algernon is a beautiful and poignant story. Daniel Keyes effectively teaches us about the issue of living...

Flowers for Algernon: Full Book Summary | SparkNotes information

A short summary of Daniel Keyes's Flowers for Algernon. This free synopsis covers all the crucial plot points of...